Dogwood Therapeutics
DWTX
10 hedge funds and large institutions have $292K invested in Dogwood Therapeutics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
1.03% more ownership
Funds ownership: 2.04% → 3.06% (+1%)
3% less capital invested
Capital invested by funds: $300K → $292K (-$7.52K)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$68.6K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$55.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.73K |
| 2 |
Citigroup
New York
|
-$762 |
| 3 |
Morgan Stanley
New York
|
-$724 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$47 |
| 5 |
Barclays
London,
United Kingdom
|
-$39 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $125K | +$45.8K | +7,776 | +35% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $69.8K | +$9.98K | +1,695 | +11% |
|
|
3
Marshall Wace
London,
United Kingdom
| $48.5K | +$68.6K | +11,655 | New |
|
|
4
Bank of America
Charlotte,
North Carolina
| $39.2K | +$55.3K | +9,399 | +58,744% |
|
|
5
UBS Group
Zurich,
Switzerland
| $7.27K | +$10.3K | +1,748 | New |
|
|
6
Morgan Stanley
New York
| $1.98K | -$724 | -123 | -21% |
|
|
AWM
7
Activest Wealth Management
Aventure,
Florida
| $499 | – | – | – |
|
8
BlackRock
New York
| $125 | – | – | – |
|
9
Group One Trading
Chicago,
Illinois
| $37 | – | – | – |
|
|
10
BNP Paribas Financial Markets
Paris,
France
| $8 | -$47 | -8 | -80% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$5.73K | -744 | Closed |
|
|
12
Citigroup
New York
| – | -$762 | -99 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$39 | -5 | Closed |
|
|
SS
14
SBI Securities
Tokyo,
Japan
| – | -$8 | -1 | Closed |
|
DWTX Hedge Fund Activity: Q4 2025 in Review
10 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q4 2025, worth a combined $292K — down 2.5% from $300K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DWTX and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Marshall Wace, opening a new position worth an estimated $68.6K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.73K sold.
- 10 institutional investors held Dogwood Therapeutics (DWTX) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $292K of Dogwood Therapeutics stock for Q4 2025, down 2.5% quarter-over-quarter.
- 2 funds opened new Dogwood Therapeutics positions in Q4 2025 and 4 closed out, a net change of -2 holders.
- The largest Dogwood Therapeutics buyer in Q4 2025 was Marshall Wace, an estimated $68.6K added.
- The largest Dogwood Therapeutics seller in Q4 2025 was Tower Research Capital (TRC), an estimated $5.73K sold.
Based on aggregated 13F filings for Q4 2025.